US Stock MarketDetailed Quotes

Coherus Oncology (CHRS)

Watchlist

1.800
+0.025+1.41%

Close May 1 16:00 ET

1.810
+0.010+0.55%

Post 17:39 ET

277.59MMarket Cap1.26P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Coherus Oncology (CHRS) Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(FY)Dec 31, 2025

(Q4)Dec 31, 2025

(Q3)Sep 30, 2025

(Q2)Jun 30, 2025

(Q1)Mar 31, 2025

(FY)Dec 31, 2024

(Q4)Dec 31, 2024

(Q3)Sep 30, 2024

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

-577.66%-138.51M

-168.92%-19.72M

25.28%-46.34M

-178.07%-46.63M

44.78%-25.83M

88.31%-20.44M

321.13%28.61M

-14.21%-62.02M

253.50%59.73M

31.96%-46.77M

Net income from continuing operations

489.41%168.02M

25.75%-37.64M

-230.49%-35.53M

2,404.52%297.77M

-154.99%-56.57M

111.98%28.51M

36.35%-50.7M

72.88%-10.75M

69.86%-12.92M

235.85%102.88M

Operating gains losses

-98.48%-315.42M

-91.84%365K

-62.82%422K

-2,869.53%-328.82M

108.22%12.61M

-42,477.60%-158.92M

--4.48M

--1.14M

---11.07M

---153.45M

Depreciation and amortization

-25.63%3.92M

-13.26%896K

-37.64%966K

-14.41%1.02M

-30.59%1.05M

39.17%5.28M

-2.82%1.03M

72.30%1.55M

34.89%1.19M

58.80%1.51M

Other non cash items

-12,695.12%-10.33M

-510.56%-4.98M

-1,199.86%-7.84M

56.02%1.63M

129.70%858K

321.62%82K

1,153.91%1.21M

12.46%713K

344.96%1.05M

-2,139.53%-2.89M

Change In working capital

-110.45%-5.84M

-70.04%16.34M

84.74%-9.39M

-131.85%-23.65M

195.44%10.86M

251.78%55.89M

756.30%54.54M

-122.77%-61.53M

1,292.23%74.26M

-21.74%-11.38M

-Change in receivables

-37.36%93.56M

-114.80%-8.34M

-154.64%-4.27M

-27.88%55.27M

493.20%50.89M

199.12%149.35M

227.85%56.33M

110.37%7.81M

292.18%76.64M

0.59%8.58M

-Change in inventory

46.46%-17.11M

82.74%-1.11M

135.72%2.48M

153.08%3.77M

-94.19%-22.24M

31.63%-31.95M

45.28%-6.45M

63.89%-6.94M

45.55%-7.1M

-328.87%-11.46M

-Change in prepaid assets

33.56%5.11M

43.41%3.66M

217.08%1.93M

308.43%4.67M

-199.67%-5.15M

-78.96%3.83M

-24.38%2.55M

-116.92%-1.65M

-291.79%-2.24M

31.78%5.16M

-Change in payables and accrued expense

-132.43%-151.85M

-757.73%-29.67M

51.84%-32.72M

-861.63%-78.65M

11.72%-10.81M

-145.87%-65.33M

-92.33%4.51M

-218.84%-67.93M

-77.32%10.33M

35.98%-12.24M

-Change in other working capital

--64.45M

--51.81M

223.09%23.19M

-159.49%-8.71M

-28.93%-1.84M

----

--7.18M

---3.36M

---1.42M

Cash from discontinued investing activities

Operating cash flow

-577.66%-138.51M

-168.92%-19.72M

25.28%-46.34M

-178.07%-46.63M

44.78%-25.83M

88.31%-20.44M

321.13%28.61M

-14.21%-62.02M

253.50%59.73M

31.96%-46.77M

Investing cash flow

Cash flow from continuing investing activities

62.85%375.09M

-423.62%-2.84M

-15,241.22%-67.23M

1,572.83%462.64M

-108.62%-17.49M

59.24%230.32M

-101.54%-542K

-99.12%444K

-33.14%27.66M

1,056.93%202.76M

Net business purchase and sale

112.61%457.81M

-67.01%-20.88M

--0

----

2,977.36%215.32M

---12.5M

--0

----

Net investment purchase and sale

-653.30%-82.38M

--5.55M

---67.2M

---20.73M

--0

-89.22%14.89M

--0

-14.93%14.89M

Net other investing changes

-410.91%-342K

4.43%12.49M

-106.08%-27K

102.34%4.68M

-109.31%-17.49M

122.36%110K

1,285.13%11.96M

194.04%444K

-58,972.65%-200.17M

722,496.15%187.88M

Cash from discontinued investing activities

Investing cash flow

62.85%375.09M

-423.62%-2.84M

-15,241.22%-67.23M

1,572.83%462.64M

-108.62%-17.49M

59.24%230.32M

-101.54%-542K

-99.12%444K

-33.14%27.66M

1,056.93%202.76M

Financing cash flow

Cash flow from continuing financing activities

-46.39%-273.71M

3,398.27%8.08M

101.20%2K

-49.81%-281.52M

-129.76%-264K

-368.64%-186.97M

-36.89%231K

-101.50%-167K

-445.93%-187.93M

-76.68%887K

Net issuance payments of debt

-25.71%-280.84M

---47.65M

--0

----

---223.41M

--0

---141K

----

Net common stock issuance

442.54%7.89M

--7.89M

--0

-97.97%1.46M

--0

-100.10%-52K

-77.95%1.51M

Proceeds from stock option exercised by employees

-61.88%353K

-31.54%165K

--0

----

-63.00%926K

-75.80%241K

--0

-49.30%685K

182.52%291K

Net other financing activities

-103.27%-1.12M

476,840.00%47.67M

107.69%2K

-239.81%-48.53M

57.42%-264K

836.92%34.05M

98.10%-10K

93.25%-26K

6,115.42%34.71M

80.22%-620K

Cash from discontinued financing activities

Financing cash flow

-46.39%-273.71M

3,398.27%8.08M

101.20%2K

-49.81%-281.52M

-129.76%-264K

-368.64%-186.97M

-36.89%231K

-101.50%-167K

-445.93%-187.93M

-76.68%887K

Net cash flow

Beginning cash position

22.17%126.25M

5.76%103.59M

35.98%217.16M

-68.23%82.67M

22.17%126.25M

61.51%103.34M

21.36%97.95M

117.68%159.69M

1,469.05%260.23M

61.51%103.34M

Current changes in cash

-262.09%-37.13M

-151.15%-14.47M

-83.94%-113.56M

233.77%134.48M

-127.78%-43.58M

-41.80%22.91M

25.03%28.3M

-939.87%-61.74M

-277.08%-100.54M

430.96%156.88M

End cash Position

-29.41%89.12M

5.76%103.59M

35.98%217.16M

-68.23%82.67M

22.17%126.25M

21.36%97.95M

117.68%159.69M

1,469.05%260.23M

Free cash flow

-577.66%-138.51M

-168.92%-19.72M

25.28%-46.34M

-178.07%-46.63M

44.78%-25.83M

88.31%-20.44M

321.13%28.61M

-14.21%-62.02M

253.50%59.73M

31.96%-46.77M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(FY)Dec 31, 2025	(Q4)Dec 31, 2025	(Q3)Sep 30, 2025	(Q2)Jun 30, 2025	(Q1)Mar 31, 2025	(FY)Dec 31, 2024	(Q4)Dec 31, 2024	(Q3)Sep 30, 2024	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	-577.66%-138.51M	-168.92%-19.72M	25.28%-46.34M	-178.07%-46.63M	44.78%-25.83M	88.31%-20.44M	321.13%28.61M	-14.21%-62.02M	253.50%59.73M	31.96%-46.77M
Net income from continuing operations	489.41%168.02M	25.75%-37.64M	-230.49%-35.53M	2,404.52%297.77M	-154.99%-56.57M	111.98%28.51M	36.35%-50.7M	72.88%-10.75M	69.86%-12.92M	235.85%102.88M
Operating gains losses	-98.48%-315.42M	-91.84%365K	-62.82%422K	-2,869.53%-328.82M	108.22%12.61M	-42,477.60%-158.92M	--4.48M	--1.14M	---11.07M	---153.45M
Depreciation and amortization	-25.63%3.92M	-13.26%896K	-37.64%966K	-14.41%1.02M	-30.59%1.05M	39.17%5.28M	-2.82%1.03M	72.30%1.55M	34.89%1.19M	58.80%1.51M
Other non cash items	-12,695.12%-10.33M	-510.56%-4.98M	-1,199.86%-7.84M	56.02%1.63M	129.70%858K	321.62%82K	1,153.91%1.21M	12.46%713K	344.96%1.05M	-2,139.53%-2.89M
Change In working capital	-110.45%-5.84M	-70.04%16.34M	84.74%-9.39M	-131.85%-23.65M	195.44%10.86M	251.78%55.89M	756.30%54.54M	-122.77%-61.53M	1,292.23%74.26M	-21.74%-11.38M
-Change in receivables	-37.36%93.56M	-114.80%-8.34M	-154.64%-4.27M	-27.88%55.27M	493.20%50.89M	199.12%149.35M	227.85%56.33M	110.37%7.81M	292.18%76.64M	0.59%8.58M
-Change in inventory	46.46%-17.11M	82.74%-1.11M	135.72%2.48M	153.08%3.77M	-94.19%-22.24M	31.63%-31.95M	45.28%-6.45M	63.89%-6.94M	45.55%-7.1M	-328.87%-11.46M
-Change in prepaid assets	33.56%5.11M	43.41%3.66M	217.08%1.93M	308.43%4.67M	-199.67%-5.15M	-78.96%3.83M	-24.38%2.55M	-116.92%-1.65M	-291.79%-2.24M	31.78%5.16M
-Change in payables and accrued expense	-132.43%-151.85M	-757.73%-29.67M	51.84%-32.72M	-861.63%-78.65M	11.72%-10.81M	-145.87%-65.33M	-92.33%4.51M	-218.84%-67.93M	-77.32%10.33M	35.98%-12.24M
-Change in other working capital	--64.45M	--51.81M	223.09%23.19M	-159.49%-8.71M	-28.93%-1.84M	----	----	--7.18M	---3.36M	---1.42M
Cash from discontinued investing activities
Operating cash flow	-577.66%-138.51M	-168.92%-19.72M	25.28%-46.34M	-178.07%-46.63M	44.78%-25.83M	88.31%-20.44M	321.13%28.61M	-14.21%-62.02M	253.50%59.73M	31.96%-46.77M
Investing cash flow
Cash flow from continuing investing activities	62.85%375.09M	-423.62%-2.84M	-15,241.22%-67.23M	1,572.83%462.64M	-108.62%-17.49M	59.24%230.32M	-101.54%-542K	-99.12%444K	-33.14%27.66M	1,056.93%202.76M
Net business purchase and sale	112.61%457.81M	-67.01%-20.88M	--0	----	----	2,977.36%215.32M	---12.5M	--0	----	----
Net investment purchase and sale	-653.30%-82.38M	--5.55M	---67.2M	---20.73M	--0	-89.22%14.89M	--0	--0	--0	-14.93%14.89M
Net other investing changes	-410.91%-342K	4.43%12.49M	-106.08%-27K	102.34%4.68M	-109.31%-17.49M	122.36%110K	1,285.13%11.96M	194.04%444K	-58,972.65%-200.17M	722,496.15%187.88M
Cash from discontinued investing activities
Investing cash flow	62.85%375.09M	-423.62%-2.84M	-15,241.22%-67.23M	1,572.83%462.64M	-108.62%-17.49M	59.24%230.32M	-101.54%-542K	-99.12%444K	-33.14%27.66M	1,056.93%202.76M
Financing cash flow
Cash flow from continuing financing activities	-46.39%-273.71M	3,398.27%8.08M	101.20%2K	-49.81%-281.52M	-129.76%-264K	-368.64%-186.97M	-36.89%231K	-101.50%-167K	-445.93%-187.93M	-76.68%887K
Net issuance payments of debt	-25.71%-280.84M	---47.65M	--0	----	----	---223.41M	--0	---141K	----	----
Net common stock issuance	442.54%7.89M	--7.89M	--0	--0	--0	-97.97%1.46M	--0	--0	-100.10%-52K	-77.95%1.51M
Proceeds from stock option exercised by employees	-61.88%353K	-31.54%165K	--0	----	----	-63.00%926K	-75.80%241K	--0	-49.30%685K	182.52%291K
Net other financing activities	-103.27%-1.12M	476,840.00%47.67M	107.69%2K	-239.81%-48.53M	57.42%-264K	836.92%34.05M	98.10%-10K	93.25%-26K	6,115.42%34.71M	80.22%-620K
Cash from discontinued financing activities
Financing cash flow	-46.39%-273.71M	3,398.27%8.08M	101.20%2K	-49.81%-281.52M	-129.76%-264K	-368.64%-186.97M	-36.89%231K	-101.50%-167K	-445.93%-187.93M	-76.68%887K
Net cash flow
Beginning cash position	22.17%126.25M	5.76%103.59M	35.98%217.16M	-68.23%82.67M	22.17%126.25M	61.51%103.34M	21.36%97.95M	117.68%159.69M	1,469.05%260.23M	61.51%103.34M
Current changes in cash	-262.09%-37.13M	-151.15%-14.47M	-83.94%-113.56M	233.77%134.48M	-127.78%-43.58M	-41.80%22.91M	25.03%28.3M	-939.87%-61.74M	-277.08%-100.54M	430.96%156.88M
End cash Position	-29.41%89.12M	-29.41%89.12M	5.76%103.59M	35.98%217.16M	-68.23%82.67M	22.17%126.25M	22.17%126.25M	21.36%97.95M	117.68%159.69M	1,469.05%260.23M
Free cash flow	-577.66%-138.51M	-168.92%-19.72M	25.28%-46.34M	-178.07%-46.63M	44.78%-25.83M	88.31%-20.44M	321.13%28.61M	-14.21%-62.02M	253.50%59.73M	31.96%-46.77M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--	--	--	--

No. Symbol 5D % Chg

Middle East conflict spreads to the stock market! How should investors respond?

On May 1, the more than two-month-long military conflict involving the US, Israel, and Iran will reach a legal milestone, potentially increa Show More

牛牛課堂

Mar 4 17:09

Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.

牛牛課堂

Mar 18 18:18

Hormuz, Term Structure and USO: Navigating the Energy Storm